- Home
- SWIN vs BNR Comparison
SWIN vs BNR Comparison
Compare SWIN & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- BNR
- Stock Information
- Founded
- SWIN 2017
- BNR 2014
- Country
- SWIN Hong Kong
- BNR China
- Employees
- SWIN N/A
- BNR N/A
- Industry
- SWIN
- BNR Medical Specialities
- Sector
- SWIN
- BNR Health Care
- Exchange
- SWIN Nasdaq
- BNR Nasdaq
- Market Cap
- SWIN 214.1M
- BNR 38.3M
- IPO Year
- SWIN 2023
- BNR 2020
- Fundamental
- Price
- SWIN $3.93
- BNR $6.47
- Analyst Decision
- SWIN
- BNR
- Analyst Count
- SWIN 0
- BNR 0
- Target Price
- SWIN N/A
- BNR N/A
- AVG Volume (30 Days)
- SWIN 208.1K
- BNR 53.8K
- Earning Date
- SWIN 08-21-2025
- BNR 08-21-2025
- Dividend Yield
- SWIN N/A
- BNR N/A
- EPS Growth
- SWIN N/A
- BNR N/A
- EPS
- SWIN N/A
- BNR N/A
- Revenue
- SWIN $3,316,000.00
- BNR $72,112,038.00
- Revenue This Year
- SWIN $29.79
- BNR $136.32
- Revenue Next Year
- SWIN $54.60
- BNR N/A
- P/E Ratio
- SWIN N/A
- BNR N/A
- Revenue Growth
- SWIN N/A
- BNR 0.53
- 52 Week Low
- SWIN $1.16
- BNR $2.18
- 52 Week High
- SWIN $4.40
- BNR $9.48
- Technical
- Relative Strength Index (RSI)
- SWIN 62.05
- BNR 60.79
- Support Level
- SWIN $3.70
- BNR $5.81
- Resistance Level
- SWIN $3.99
- BNR $9.48
- Average True Range (ATR)
- SWIN 0.35
- BNR 0.90
- MACD
- SWIN -0.03
- BNR 0.12
- Stochastic Oscillator
- SWIN 93.02
- BNR 45.86
About SWIN Solowin Holdings
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.